Addition to National List of Essentiel Drugs (NED)
On 15 July 2016, the committee for the National Essential Drugs (NED) list in Thailand included Medabon® to the NED list. Medabon® is a quality-assured misoprostol-mifepristone combination product that has been registered in Thailand since 2014.
New country registration for Medabon®
Additionally, on 26 July 2016, Medabon® registration was achieved in Hong Kong. Hong Kong is the 26th country to register this important product.
More information can be found on our dedicated programme page. This page also contains information about Concept Foundation’s work in increasing access to safe medical abortion.